8-K: FitLife Brands Announces Strong Preliminary 2023 Results and Participation in Roth Conference

FitLife Brands anticipates significant revenue and adjusted EBITDA growth for 2023, alongside a reduction in outstanding debt.

Summary

• FitLife Brands announced its participation in the 36th Annual Roth Conference on March 18, 2024.
• The company released preliminary financial results for the year ended December 31, 2023.
• Net revenue for 2023 is expected to be between $52 and $53 million, representing an 81-84% increase compared to 2022.
• Adjusted EBITDA for 2023 is anticipated to be between $10.0 and $10.5 million, a 49-57% increase compared to 2022.
• As of December 31, 2023, the company had $20.1 million outstanding on its term loan and no balance on its revolver.
• The company had $1.1 million of unrestricted cash and $0.8 million of restricted cash as of December 31, 2023.
• Subsequent to year-end, FitLife made a $1.1 million scheduled and a $2.5 million voluntary payment on its term loan, reducing outstanding debt to $16.5 million and net debt to $15.1 million.

Sentiment

Score: 8

Explanation: The document presents very positive preliminary financial results, with strong growth in revenue and EBITDA, and a reduction in debt. The company is also actively engaging with investors at a conference. The forward looking statements are cautious but overall the sentiment is positive.

Positives

• The company anticipates substantial revenue growth of 81-84% for 2023.
• Adjusted EBITDA is expected to increase by 49-57% in 2023.
• FitLife has reduced its outstanding debt through scheduled and voluntary payments.
• The company has a positive cash balance with $1.1 million in unrestricted cash.

Risks

• The company's future results may be materially different from forward-looking statements due to various risks and uncertainties.
• These risks include the ability to continue revenue growth, successfully integrate acquisitions, and maintain positive cash flow.
• The company's filings with the SEC, including Form 10-K and 10-Q, detail further risk factors.

Future Outlook

The company anticipates continued growth in revenue and profitability, but cautions that actual results may vary due to various risks and uncertainties.

Management Comments

• FitLife management is participating in the 36th Annual Roth Conference.
• Management has prepared an updated investor presentation for the conference.

Industry Context

The announcement reflects a positive trend in the nutritional supplements and wellness products market, with FitLife demonstrating strong growth in revenue and profitability.

Comparison to Industry Standards

• While specific competitor data is not provided, the 81-84% revenue growth and 49-57% adjusted EBITDA growth are significant and suggest strong performance compared to industry averages.
• Companies like GNC, which FitLife distributes through, are established players, and FitLife's growth indicates a successful strategy in a competitive market.
• The reduction in debt and positive cash position also place FitLife in a favorable position compared to companies with higher debt loads.

Stakeholder Impact

• Shareholders will likely view the strong financial results and debt reduction positively.
• Employees may benefit from the company's growth and improved financial position.
• Customers may see continued investment in product development and availability.
• Creditors will be reassured by the company's reduced debt and improved financial health.

Next Steps

• FitLife Brands will participate in the 36th Annual Roth Conference on March 18, 2024.
• The company will file its full financial results for fiscal 2023 on Form 10-K prior to April 1, 2024.

Key Dates

Keywords

nutritional supplements, wellness products, revenue growth, EBITDA, debt reduction, financial results, Roth Conference